P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).

• A. G. Jansen,
• V. McDonald,
• A. Newland,
• M. Morgan,
• S. Visser-Peereboom,
• K. Wilson,
• D. Eriksson,
• E. Geldman,
• O. Daykin-Pont,
• J. J. Zwaginga

Affiliations

A. G. Jansen

1 Department of Haematology, Erasmus MC, Rotterdam, Netherlands

V. McDonald

2 Department of Clinical Haematology, The Royal London Hospital, Barts Health NHS Trust

A. Newland

3 Academic Haematology Unit, Blizzard institute, Barts & The London School of Medicine & Dentistry, Queen Mary Institute of London, London

M. Morgan

4 ITP Support Association, Bolnhurst, United Kingdom

S. Visser-Peereboom

5 Swedish Orphan Biovitrum AB, Stockholm, Sweden

K. Wilson

5 Swedish Orphan Biovitrum AB, Stockholm, Sweden

D. Eriksson

5 Swedish Orphan Biovitrum AB, Stockholm, Sweden

E. Geldman

6 Wickenstones Ltd, Abingdon, United Kingdom

O. Daykin-Pont

6 Wickenstones Ltd, Abingdon, United Kingdom

J. J. Zwaginga

7 Department of Haematology, Leiden University Medical Centre, Leiden, Netherlands